Xylocaine 2% Topical Jelly is a Pharmacy Only Medicine. Each gram of Xylocaine Jelly contains lidocaine (lignocaine) hydrochloride 20 mg. Excipients with known effect: methyl hydroxybenzoate, propyl hydroxybenzoate. Xylocaine Jelly is indicated as a surface anaesthetic and lubricant to help prevent pain and discomfort during certain medical tests and procedures.
Contraindications: Known history of hypersensitivity to local anaesthetics of the amide type, or other components of the jelly. Hypersensitivity to methyl and/or propyl hydroxybenzoate (methyl-/propyl paraben), or to their metabolite para amino benzoic acid (PABA). Formulations of lignocaine containing parabens should be avoided in patients allergic to ester local anaesthetics or their metabolite PABA.
Special warnings and precautions for use: Excessive doses of lignocaine products or short intervals between doses, can resultin high plasma levels and serious adverse effects.
Interactions with other medicines and other forms of interaction Lignocaine should be used with caution in patients receiving agents structurally related to local anaesthetics, since the toxic effects are additive. Specific interaction studies with lignocaine and anti-arrhythmic drugs class III (e.g.amiodarone) have not been performed, but caution when treating patients is advised. Medicines that reduce the clearance of lignocaine (e.g. cimetidine or betablockers) may cause potentially toxic plasma concentrations when lignocaine is given in repeated high doses over a long period of time. Such interactions should be of no clinical importance following short term treatment with lignocaine (e.g. Xylocaine Jelly) at recommended doses.
Fertility, pregnancy and lactation: It is reasonable to assume that a large number of pregnant women and women of child-bearing age have been given lignocaine. No specific disturbances to the reproductive process have so far been reported, e.g. no increased incidence of malformations. Like other local anaesthetics, lignocaine may enter the mother's milk, but in such small amounts that there is generally no risk of this affecting the neonate.
Effects on ability to drive and use machines: Depending on the dose, local anaesthetics may have a very mild effect on mentalfunction and may temporarily impair locomotion and co-ordination.
Dose: Refer to datasheet for application specific dosing.
For full information on dosage, contraindications, precautions, interactions and adverse effects please refer to the data sheet available at www.medsafe.govt.nz or by clicking on the link provided with this product. NZ Sponsor: Pharmacy Retailing (NZ) Limited Trading as Healthcare Logistics. Auckland
NP21453 - Aug 2024